ALZN Alzamend Neuro Inc
Price (delayed)
$0.6774
Market cap
$4.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.04
Enterprise value
$1.11M
Highlights
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
Key stats
What are the main financial stats of ALZN
Market
Valuations
Earnings
Shares outstanding
6.6M
Market cap
$4.47M
Enterprise value
$1.11M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.07
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
EBIT
-$4.21M
EBITDA
-$4.16M
Free cash flow
-$7.4M
Per share
Balance sheet
Liquidity
EPS
-$3.04
EPS diluted
-$3.04
Free cash flow per share
-$1.34
Book value per share
$0.63
Revenue per share
$0
TBVPS
$0.76
Total assets
$4.18M
Total liabilities
$725,851
Debt
$0
Equity
$3.45M
Working capital
$3.22M
Debt to equity
0
Current ratio
5.44
Quick ratio
4.63
Net debt/EBITDA
0.81
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-149.1%
Return on equity
-504.2%
Return on invested capital
N/A
Return on capital employed
-122%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALZN stock price
How has the Alzamend Neuro stock price performed over time
Intraday
1.1%
1 week
-5.92%
1 month
-37.28%
1 year
-93.55%
YTD
-41.6%
QTD
-41.6%
Financial performance
How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
Gross margin
N/A
Net margin
N/A
ALZN's operating income has surged by 66% year-on-year and by 28% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter
Growth
What is Alzamend Neuro's growth rate over time
Valuation
What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
1.07
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
Efficiency
How efficient is Alzamend Neuro business performance
ALZN's ROA has soared by 69% YoY and by 49% from the previous quarter
Dividends
What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALZN.
Financial health
How did Alzamend Neuro financials performed over time
The company's total liabilities has shrunk by 84% YoY and by 42% QoQ
The current ratio has grown by 43% from the previous quarter
ALZN's debt is 100% smaller than its equity
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.